Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Mutant PRPF8 Causes Widespread Splicing Changes in Spliceosome Components in Retinitis Pigmentosa Patient iPSC-Derived RPE Cells

Á. Arzalluz-Luque, JL. Cabrera, H. Skottman, A. Benguria, A. Bolinches-Amorós, N. Cuenca, V. Lupo, A. Dopazo, S. Tarazona, B. Delás, M. Carballo, B. Pascual, I. Hernan, S. Erceg, D. Lukovic

. 2021 ; 15 (-) : 636969. [pub] 20210429

Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc21017859

Retinitis pigmentosa (RP) is a rare, progressive disease that affects photoreceptors and retinal pigment epithelial (RPE) cells with blindness as a final outcome. Despite high medical and social impact, there is currently no therapeutic options to slow down the progression of or cure the disease. The development of effective therapies was largely hindered by high genetic heterogeneity, inaccessible disease tissue, and unfaithful model organisms. The fact that components of ubiquitously expressed splicing factors lead to the retina-specific disease is an additional intriguing question. Herein, we sought to correlate the retinal cell-type-specific disease phenotype with the splicing profile shown by a patient with autosomal recessive RP, caused by a mutation in pre-mRNA splicing factor 8 (PRPF8). In order to get insight into the role of PRPF8 in homeostasis and disease, we capitalize on the ability to generate patient-specific RPE cells and reveal differentially expressed genes unique to RPE cells. We found that spliceosomal complex and ribosomal functions are crucial in determining cell-type specificity through differential expression and alternative splicing (AS) and that PRPF8 mutation causes global changes in splice site selection and exon inclusion that particularly affect genes involved in these cellular functions. This finding corroborates the hypothesis that retinal tissue identity is conferred by a specific splicing program and identifies retinal AS events as a framework toward the design of novel therapeutic opportunities.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21017859
003      
CZ-PrNML
005      
20210729104041.0
007      
ta
008      
210726s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fnins.2021.636969 $2 doi
035    __
$a (PubMed)33994920
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Arzalluz-Luque, Ángeles $u Department of Applied Statistics, Operations Research and Quality, Universitat Politècnica de València, València, Spain
245    10
$a Mutant PRPF8 Causes Widespread Splicing Changes in Spliceosome Components in Retinitis Pigmentosa Patient iPSC-Derived RPE Cells / $c Á. Arzalluz-Luque, JL. Cabrera, H. Skottman, A. Benguria, A. Bolinches-Amorós, N. Cuenca, V. Lupo, A. Dopazo, S. Tarazona, B. Delás, M. Carballo, B. Pascual, I. Hernan, S. Erceg, D. Lukovic
520    9_
$a Retinitis pigmentosa (RP) is a rare, progressive disease that affects photoreceptors and retinal pigment epithelial (RPE) cells with blindness as a final outcome. Despite high medical and social impact, there is currently no therapeutic options to slow down the progression of or cure the disease. The development of effective therapies was largely hindered by high genetic heterogeneity, inaccessible disease tissue, and unfaithful model organisms. The fact that components of ubiquitously expressed splicing factors lead to the retina-specific disease is an additional intriguing question. Herein, we sought to correlate the retinal cell-type-specific disease phenotype with the splicing profile shown by a patient with autosomal recessive RP, caused by a mutation in pre-mRNA splicing factor 8 (PRPF8). In order to get insight into the role of PRPF8 in homeostasis and disease, we capitalize on the ability to generate patient-specific RPE cells and reveal differentially expressed genes unique to RPE cells. We found that spliceosomal complex and ribosomal functions are crucial in determining cell-type specificity through differential expression and alternative splicing (AS) and that PRPF8 mutation causes global changes in splice site selection and exon inclusion that particularly affect genes involved in these cellular functions. This finding corroborates the hypothesis that retinal tissue identity is conferred by a specific splicing program and identifies retinal AS events as a framework toward the design of novel therapeutic opportunities.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Cabrera, Jose Luis $u Genomics Unit, Centro Nacional de Investigaciones Cardiovasculares (CNIC). Madrid, Spain
700    1_
$a Skottman, Heli $u Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
700    1_
$a Benguria, Alberto $u Genomics Unit, Centro Nacional de Investigaciones Cardiovasculares (CNIC). Madrid, Spain
700    1_
$a Bolinches-Amorós, Arantxa $u Stem Cells Therapies in Neurodegenerative Diseases Lab, Research Center Principe Felipe, Valencia, Spain $u National Stem Cell Bank-Valencia Node, Research Center Principe Felipe, Valencia, Spain
700    1_
$a Cuenca, Nicolás $u Department of Physiology, Genetics and Microbiology, University of Alicante, Alicante, Spain
700    1_
$a Lupo, Vincenzo $u Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain $u Rare Diseases Joint Units, IIS La Fe-CIPF, Valencia, Spain
700    1_
$a Dopazo, Ana $u Genomics Unit, Centro Nacional de Investigaciones Cardiovasculares (CNIC). Madrid, Spain
700    1_
$a Tarazona, Sonia $u Department of Applied Statistics, Operations Research and Quality, Universitat Politècnica de València, València, Spain
700    1_
$a Delás, Bárbara $u Unitat de Genética Molecular, Hospital de Terrassa, Terrassa, Spain
700    1_
$a Carballo, Miguel $u Unitat de Genética Molecular, Hospital de Terrassa, Terrassa, Spain
700    1_
$a Pascual, Beatriz $u Unitat de Genética Molecular, Hospital de Terrassa, Terrassa, Spain
700    1_
$a Hernan, Imma $u Unitat de Genética Molecular, Hospital de Terrassa, Terrassa, Spain
700    1_
$a Erceg, Slaven $u Stem Cells Therapies in Neurodegenerative Diseases Lab, Research Center Principe Felipe, Valencia, Spain $u National Stem Cell Bank-Valencia Node, Research Center Principe Felipe, Valencia, Spain $u Rare Diseases Joint Units, IIS La Fe-CIPF, Valencia, Spain $u Department of Neuroregeneration, Institute of Experimental Medicine, Czech Academy of Sciences, Prague, Czechia
700    1_
$a Lukovic, Dunja $u Rare Diseases Joint Units, IIS La Fe-CIPF, Valencia, Spain $u Retinal Degeneration Lab, Research Centre Principe Felipe, Valencia, Spain
773    0_
$w MED00163313 $t Frontiers in neuroscience $x 1662-4548 $g Roč. 15, č. - (2021), s. 636969
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33994920 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20210726 $b ABA008
991    __
$a 20210729104040 $b ABA008
999    __
$a ind $b bmc $g 1676445 $s 1138301
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 15 $c - $d 636969 $e 20210429 $i 1662-4548 $m Frontiers in neuroscience $n Front Neurosci $x MED00163313
LZP    __
$a Pubmed-20210726

Find record

Citation metrics

Archiving options